COMMUNIQUÉ DE PRESSE publié le 26/03/2026 à 07:29, il y a 12 jours 12 heures DEUTZ generates growth and achieves one of the highest profits in its recent history despite challenging market conditions in 2025 DEUTZ achieves significant growth and high profits in 2025 despite challenging market conditions. Strategic transformation boosts revenue and profitability. New organizational structure aims for 2030 targets Transformation Growth 2025 Profits DEUTZ
COMMUNIQUÉ DE PRESSE publié le 26/03/2026 à 07:27, il y a 12 jours 12 heures Delivery Hero reports adj EBITDA up 30% in 2025, as Quick Commerce and key markets gain momentum Delivery Hero SE reports 30% increase in adj EBITDA for 2025, showcasing growth and profitability. Strategic review and agreement for Taiwan sale Delivery Hero Strategic Review 2025 Results Adj EBITDA Taiwan Sale
COMMUNIQUÉ DE PRESSE publié le 26/03/2026 à 07:11, il y a 12 jours 12 heures Berentzen-Gruppe Aktiengesellschaft publishes its 2025 Annual Report – Berentzen Group achieves significant consolidated profit Berentzen-Gruppe Aktiengesellschaft publishes its 2025 Annual Report with a significant consolidated profit of EUR 2.4 million. Forecast for the 2026 financial year presented Dividend Financial Forecast Consolidated Profit Berentzen-Gruppe Aktiengesellschaft 2025 Annual Report
COMMUNIQUÉ DE PRESSE publié le 26/03/2026 à 07:07, il y a 12 jours 12 heures Heidelberg Pharma Announces Financial Figures and Reports on Business Performance in 2025 and Outlook for 2026 Heidelberg Pharma AG reports financial figures, business performance in 2025, and outlook for 2026, including CEO appointment, cost-cutting program, and extended cash runway. Fast Track designation for HDP-101 by FDA Financial Figures Outlook Business Performance Heidelberg Pharma Fast Track Designation
COMMUNIQUÉ DE PRESSE publié le 26/03/2026 à 07:05, il y a 12 jours 12 heures Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children Norgine announces Swissmedic approval of PEDMARQSI(R) for the prevention of cisplatin induced hearing loss in children. PEDMARQSI(R) becomes the first treatment in Switzerland for this medical need Children Swissmedic Approval Norgine PEDMARQSI Cisplatin Induced Hearing Loss
COMMUNIQUÉ DE PRESSE publié le 26/03/2026 à 07:05, il y a 12 jours 12 heures EDAG Group: Market uncertainty and delayed awarding of projects shape FY 2025 – Strategic measures accelerated to restore sustainable growth and competitiveness EDAG Group's FY 2025 marked by market uncertainty and delayed projects. Strategic measures in place to enhance growth and competitiveness. FY 2026 outlook entails challenges and positive EBIT expectations Market Uncertainty Strategic Measures EDAG Group FY 2025 FY 2026 Outlook
COMMUNIQUÉ DE PRESSE publié le 26/03/2026 à 07:00, il y a 12 jours 12 heures WashTec AG: New record revenue of €498.6m with further increase in EBIT margin to 9.8% - at con-stant exchange rates revenue exceeds €500m for the first time WashTec AG achieves record revenue of €498.6m, with EBIT margin rising to 9.8%. Positive 2025 fiscal year results led by growth in Europe and other segment EBIT Margin Record Revenue Efficiency Programs WashTec AG Fiscal Year 2025
COMMUNIQUÉ DE PRESSE publié le 26/03/2026 à 07:00, il y a 12 jours 12 heures MSCI upgrades Leonteq's ESG rating to AAA Leonteq AG announced that MSCI upgraded its ESG rating to AAA, positioning the company as an industry leader in sustainability practices Sustainability ESG Rating MSCI Leonteq AG AAA
COMMUNIQUÉ DE PRESSE publié le 26/03/2026 à 07:00, il y a 12 jours 12 heures Westwing delivers strong profitability in 2025 and aims for growth in 2026 Westwing Group SE reports strong profitability in 2025 and plans for growth in 2026, exceeding financial targets and achieving operational milestones E-commerce Financial Results Profitability Westwing Group SE Growth
COMMUNIQUÉ DE PRESSE publié le 26/03/2026 à 07:00, il y a 12 jours 12 heures Brockhaus Technologies AG: Revenue increases in 2025 by +10% to €225 million, with an adjusted EBITDA margin of 20.6%; sale of the Bikeleasing stake Brockhaus Technologies AG reports a 10% revenue increase in 2025 to €225 million with a 20.6% adjusted EBITDA margin. Sale of Bikeleasing stake boosts financial flexibility Revenue Increase EBITDA Margin Brockhaus Technologies AG Financial Flexibility Bikeleasing Stake
Publié le 07/04/2026 à 18:00, il y a 1 heure 30 minutes LDC : Chiffre d’affaires du 4 ème trimestre 2025-2026. Solide croissance du chiffre d’affaires au 4ème trimestre 2025-2026 et révision à la hausse des objectifs.
Publié le 07/04/2026 à 17:57, il y a 1 heure 33 minutes Peugeot Invest publishes its 2025 Universal Registration Document
Publié le 07/04/2026 à 17:57, il y a 1 heure 33 minutes Mise à disposition du Document d’enregistrement universel 2025
Publié le 07/04/2026 à 17:45, il y a 1 heure 45 minutes ENGIE accelerates the deployment of battery storage with nearly 400 MW of new projects in Europe
Publié le 07/04/2026 à 17:45, il y a 1 heure 45 minutes ENGIE accélère le déploiement du stockage par batteries avec près de 400 MW de nouveaux projets en Europe
Publié le 07/04/2026 à 15:00, il y a 4 heures 30 minutes Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Publié le 07/04/2026 à 14:45, il y a 4 heures 45 minutes Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Publié le 07/04/2026 à 14:40, il y a 4 heures 50 minutes bioEnergy Development Inc. Advances Domestic Activated Carbon Production Worth Up to $30 Million Over 5 Years
Publié le 07/04/2026 à 14:30, il y a 5 heures Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Publié le 07/04/2026 à 14:30, il y a 5 heures Sekur Private Data Announces Philip Oakley and Kenneth Rogers as Members of Strategic Advisory Board
Publié le 07/04/2026 à 17:45, il y a 1 heure 45 minutes VAZIVA SA: Mise à jour des modalités de l’émission d’obligations convertibles en actions nouvelles (OCA) de 8 M€ à un taux de 7,0% par an et à maturité de 3 ans
Publié le 07/04/2026 à 17:45, il y a 1 heure 45 minutes FIGEAC AÉRO: INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 07/04/2026 à 17:40, il y a 1 heure 50 minutes VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Publié le 07/04/2026 à 16:32, il y a 2 heures 58 minutes Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Publié le 07/04/2026 à 16:30, il y a 3 heures From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring